Cannabis Stocks Rally Hard in Best Weekly Performance This Year
Major cannabis equities surge across the board as sector momentum builds, marking strongest weekly gains of 2024 amid shifting market dynamics.
Cannabis equities are posting their strongest weekly performance of 2024, with major operators and ancillary companies rallying across multiple exchanges. The AdvisorShares Pure US Cannabis ETF (MSOS) has climbed over 8% this week, while individual names like Curaleaf Holdings (CURLF), Green Thumb Industries (GTBIF), and Trulieve Cannabis (TCNNF) have posted double-digit gains that outpace broader market indices.
The rally comes as institutional investors rotate back into beaten-down cannabis names that have underperformed significantly since their 2021 peaks. Multi-state operators trading at substantial discounts to historical valuations are attracting value-focused funds, particularly as Q3 earnings demonstrated resilient revenue growth despite pricing pressures in key markets like California and Colorado.
Rescheduling momentum continues to drive speculative positioning, with traders betting on potential federal policy shifts that could unlock interstate commerce and institutional capital access. The Drug Enforcement Administration's ongoing review of cannabis classification from Schedule I to Schedule III represents the most substantive federal reform catalyst in decades, creating tailwinds for companies with strong balance sheets and operational scale.
Canadian licensed producers are also participating in the broader sector rally, though with more muted gains reflecting their mature market dynamics and ongoing oversupply challenges. Canopy Growth (CGC) and Tilray Brands (TLRY) have posted modest weekly gains as investors position for potential US market entry opportunities should federal barriers fall.
The weekly surge breaks a prolonged period of sector underperformance that saw cannabis stocks lag traditional growth sectors throughout most of 2024. However, technical indicators suggest the rally may face resistance at key levels, with many names still trading well below their 52-week highs despite this week's momentum. Sustained gains will likely depend on concrete regulatory developments and continued operational execution from major operators heading into the critical holiday selling season.